Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 125 articles:
HTML format

Single Articles

    January 2021
  1. ZHOU M, Wong CK, Un KC, Lau YM, et al
    Cardiovascular sequalae in uncomplicated COVID-19 survivors.
    PLoS One. 2021;16:e0246732.
    PubMed     Abstract available

  2. KOOK H, Kim HD, Shim J, Kim YH, et al
    Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    PLoS One. 2021;16:e0244723.
    PubMed     Abstract available

  3. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
    The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
    PLoS One. 2021;16:e0245752.
    PubMed     Abstract available

  4. REZAEI-DARZI E, Mehdipour P, Di Cesare M, Farzadfar F, et al
    Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
    PLoS One. 2021;16:e0246253.
    PubMed     Abstract available

  5. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed     Abstract available

  6. SILAND JE, Nguyen BO, de With RR, Van Gelder IC, et al
    Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.
    PLoS One. 2021;16:e0246907.
    PubMed     Abstract available

  7. SCHMIDT MM, Griffin JM, McCabe P, Stuart-Mullen L, et al
    Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation.
    PLoS One. 2021;16:e0246861.
    PubMed     Abstract available

  8. QAZI JZ, Schnitzer ME, Cote R, Martel MJ, et al
    Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
    PLoS One. 2021;16:e0246691.
    PubMed     Abstract available

  9. XIAOKERETI J, Guo YK, Dong ZY, Ma M, et al
    Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model.
    PLoS One. 2021;16:e0247308.
    PubMed     Abstract available

  10. SHIYOVICH A, Chodick G, Azani L, Tirosh M, et al
    Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis.
    PLoS One. 2021;16:e0247097.
    PubMed     Abstract available

  11. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
    COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
    PLoS One. 2021;16:e0255976.
    PubMed     Abstract available

  12. CHAU E, Rosella LC, Mondor L, Wodchis WP, et al
    Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0245193.
    PubMed     Abstract available

  13. MATUZ A, van der Linden D, Kisander Z, Hernadi I, et al
    Enhanced cardiac vagal tone in mental fatigue: Analysis of heart rate variability in Time-on-Task, recovery, and reactivity.
    PLoS One. 2021;16:e0238670.
    PubMed     Abstract available

  14. CHO SS, Jo SH, Kim HJ, Lee MH, et al
    Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.
    PLoS One. 2021;16:e0248386.
    PubMed     Abstract available

  15. KOZIEL M, Teutsch C, Halperin JL, Rothman KJ, et al
    Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
    PLoS One. 2021;16:e0249524.
    PubMed     Abstract available

  16. LIN YC, Chen BL, Shih CM, Lin FY, et al
    Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.
    PLoS One. 2021;16:e0249940.
    PubMed     Abstract available

  17. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available

  18. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available

  19. ABAD R, Collart O, Ganesan P, Rogers AJ, et al
    Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry.
    PLoS One. 2021;16:e0249873.
    PubMed     Abstract available

  20. GOMES FREITAS C, Walsh M, Coutinho EL, Vincenzo de Paola AA, et al
    Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial.
    PLoS One. 2021;16:e0248567.
    PubMed     Abstract available

  21. ALAMMARI M, Sultana K, Alturaiki A, Thomas A, et al
    The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.
    PLoS One. 2021;16:e0250502.
    PubMed     Abstract available

  22. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available

  23. HAIDL H, Gaugler J, Cvirn G, Jasser-Nitsche H, et al
    Impact of electric cardioversion on platelet activation.
    PLoS One. 2021;16:e0250353.
    PubMed     Abstract available

  24. DHILLON GS, Ahluwalia N, Honarbakhsh S, Graham A, et al
    Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
    PLoS One. 2021;16:e0248951.
    PubMed     Abstract available

  25. JANG S, Ogunmoroti O, Zhao D, Fashanu OE, et al
    The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2021;16:e0248644.
    PubMed     Abstract available

  26. RAVVAZ K, Weissert JA, Jahangir A, Ruff CT, et al
    Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
    PLoS One. 2021;16:e0248134.
    PubMed     Abstract available

  27. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    PubMed     Abstract available

  28. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
    High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
    PLoS One. 2021;16:e0251178.
    PubMed     Abstract available

  29. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
    PLoS One. 2021;16:e0251124.
    PubMed     Abstract available

  30. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
    J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
    PLoS One. 2021;16:e0257982.
    PubMed     Abstract available

  31. GUO A, Smith S, Khan YM, Langabeer Ii JR, et al
    Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records.
    PLoS One. 2021;16:e0239007.
    PubMed     Abstract available

  32. SYOMIN F, Osepyan A, Tsaturyan A
    Computationally efficient model of myocardial electromechanics for multiscale simulations.
    PLoS One. 2021;16:e0255027.
    PubMed     Abstract available

  33. MASJEDI M, Jungen C, Kuklik P, Alken FA, et al
    A novel algorithm for 3-D visualization of electrogram duration for substrate-mapping in patients with ischemic heart disease and ventricular tachycardia.
    PLoS One. 2021;16:e0254683.
    PubMed     Abstract available

  34. REICHMANN-ARIEL D, Sadeh R, Galante O, Almog Y, et al
    Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava.
    PLoS One. 2021;16:e0252726.
    PubMed     Abstract available

  35. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available

  36. ROSENSTROM S, Risom SS, Ejlertsen C, Hove JD, et al
    Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study.
    PLoS One. 2021;16:e0254130.
    PubMed     Abstract available

  37. LIU XH, Xu Q, Luo T, Zhang L, et al
    Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies.
    PLoS One. 2021;16:e0253709.
    PubMed     Abstract available

  38. MALLADI CL, Darden D, Aldaas O, Mylavarapu PS, et al
    Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
    PLoS One. 2021;16:e0253266.
    PubMed     Abstract available

  39. SLAUGHTER MS, Monreal G, Koenig SC, Giridharan GA, et al
    Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
    PLoS One. 2021;16:e0253299.
    PubMed     Abstract available

  40. LEE HJ, Kim HK, Kim BS, Han KD, et al
    Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    PLoS One. 2021;16:e0253310.
    PubMed     Abstract available

  41. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available

  42. HAMMER KP, Mustroph J, Stauber T, Birchmeier W, et al
    Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice.
    PLoS One. 2021;16:e0252649.
    PubMed     Abstract available

  43. MISGANAW A, Sitote M, Jemal S, Melese E, et al
    Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0252465.
    PubMed     Abstract available

  44. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
    Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
    PLoS One. 2021;16:e0258313.
    PubMed     Abstract available

  45. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
    PLoS One. 2021;16:e0258377.
    PubMed     Abstract available

  46. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
    Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
    PLoS One. 2021;16:e0258285.
    PubMed     Abstract available

  47. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
    Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    PLoS One. 2021;16:e0258276.
    PubMed     Abstract available

  48. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
    The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
    PLoS One. 2021;16:e0255466.
    PubMed     Abstract available

  49. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available

  50. GARCIA-VILLAFRANCA A, Barrera-Lopez L, Pose-Bar M, Pardellas-Santiago E, et al
    De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review.
    PLoS One. 2021;16:e0258602.
    PubMed     Abstract available

  51. PIAYDA K, Afzal S, Nielsen-Kudsk JE, Schmidt B, et al
    Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.
    PLoS One. 2021;16:e0255721.
    PubMed     Abstract available

    January 2020
  52. BOWRIN K, Briere JB, Fauchier L, Coleman C, et al
    Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
    PLoS One. 2020;15:e0225301.
    PubMed     Abstract available

  53. MCALISTER FA, Mian R, Oldgren J, Wallentin L, et al
    Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.
    PLoS One. 2020;15:e0226259.
    PubMed     Abstract available

  54. CHANG NC, Hu P, Chen TH, Mao CT, et al
    Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227571.
    PubMed     Abstract available

  55. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed     Abstract available

  56. KIM T, Kim KS, Suh GJ, Kwon WY, et al
    Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation.
    PLoS One. 2020;15:e0228111.
    PubMed     Abstract available

  57. HSIEH HL, Hsu SC, Cheng HS, Chen CY, et al
    The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis.
    PLoS One. 2020;15:e0228405.
    PubMed     Abstract available

  58. WALEK P, Sielski J, Gorczyca I, Roskal-Walek J, et al
    Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0228239.
    PubMed     Abstract available

  59. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available

  60. MOUSAVI S, Fotoohinasab A, Afghah F
    Single-modal and multi-modal false arrhythmia alarm reduction using attention-based convolutional and recurrent neural networks.
    PLoS One. 2020;15:e0226990.
    PubMed     Abstract available

  61. HSIEH YC, Hsieh WH, Li CH, Liao YC, et al
    Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia.
    PLoS One. 2020;15:e0228818.
    PubMed     Abstract available

  62. FARRAHA M, Lu J, Trivic I, Barry MA, et al
    Development of a sheep model of atrioventricular block for the application of novel therapies.
    PLoS One. 2020;15:e0229092.
    PubMed     Abstract available

  63. GLINGE C, Engstrom T, Midgley SE, Tanck MWT, et al
    Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure.
    PLoS One. 2020;15:e0226936.
    PubMed     Abstract available

  64. ZHAO H, Liu M, Chen Z, Mei K, et al
    Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes.
    PLoS One. 2020;15:e0227262.
    PubMed     Abstract available

  65. LOWN M, Brown M, Brown C, Yue AM, et al
    Machine learning detection of Atrial Fibrillation using wearable technology.
    PLoS One. 2020;15:e0227401.
    PubMed     Abstract available

  66. STOCKIGT F, Eichhorn L, Beiert T, Knappe V, et al
    Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.
    PLoS One. 2020;15:e0228913.
    PubMed     Abstract available

  67. ROMERO D, Behar N, Petit B, Probst V, et al
    Dynamic changes in ventricular depolarization during exercise in patients with Brugada syndrome.
    PLoS One. 2020;15:e0229078.
    PubMed     Abstract available

  68. ZHANG C, Gao J, Guo Y, Xing A, et al
    Association of atrial fibrillation and clinical outcomes in adults with chronic kidney disease: A propensity score-matched analysis.
    PLoS One. 2020;15:e0230189.
    PubMed     Abstract available

  69. ZIMIK S, Pandit R, Majumder R
    Anisotropic shortening in the wavelength of electrical waves promotes onset of electrical turbulence in cardiac tissue: An in silico study.
    PLoS One. 2020;15:e0230214.
    PubMed     Abstract available

  70. SHINGU Y, Takada S, Yokota T, Shirakawa R, et al
    Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation.
    PLoS One. 2020;15:e0224713.
    PubMed     Abstract available

  71. MARCHENA M, Echebarria B
    Influence of the tubular network on the characteristics of calcium transients in cardiac myocytes.
    PLoS One. 2020;15:e0231056.
    PubMed     Abstract available

  72. KUBITZ JC, Schulte-Uentrop L, Zoellner C, Lemke M, et al
    Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery.
    PLoS One. 2020;15:e0231378.
    PubMed     Abstract available

  73. MANDALA S, Cai Di T, Sunar MS, Adiwijaya, et al
    ECG-based prediction algorithm for imminent malignant ventricular arrhythmias using decision tree.
    PLoS One. 2020;15:e0231635.
    PubMed     Abstract available

  74. KOWALEWSKI M, Jasinski M, Staromlynski J, Zembala M, et al
    On-Pump vs Off-Pump coronary artery bypass surgery in atrial fibrillation. Analysis from the polish national registry of cardiac surgery procedures (KROK).
    PLoS One. 2020;15:e0231950.
    PubMed     Abstract available

  75. YAN J, Li H, Bu H, Jiao K, et al
    Aging-associated sinus arrest and sick sinus syndrome in adult zebrafish.
    PLoS One. 2020;15:e0232457.
    PubMed     Abstract available

  76. LARUPA SANTOS J, Rodriguez I, S Olesen M, Hjorth Bentzen B, et al
    Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.
    PLoS One. 2020;15:e0232719.
    PubMed     Abstract available

  77. PRITCHETT RV, Clarke JL, Jolly K, Clarkesmith D, et al
    Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis.
    PLoS One. 2020;15:e0232484.
    PubMed     Abstract available

  78. CLAUSS S, Schuttler D, Bleyer C, Vlcek J, et al
    Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.
    PLoS One. 2020;15:e0232374.
    PubMed     Abstract available

  79. CHIOU YA, Cheng LK, Lin SF
    Effects of high-frequency biphasic shocks on ventricular vulnerability and defibrillation outcomes through synchronized virtual electrode responses.
    PLoS One. 2020;15:e0232529.
    PubMed     Abstract available

  80. CHUN KJ, Gwag HB, Hwang JK, Park SJ, et al
    Is transjugular insertion of a temporary pacemaker a safe and effective approach?
    PLoS One. 2020;15:e0233129.
    PubMed     Abstract available

  81. ESCOBAR C, Borras X, Bover Freire R, Gonzalez-Juanatey C, et al
    A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study.
    PLoS One. 2020;15:e0231565.
    PubMed     Abstract available

  82. SWANSON KM, Zhu Y, Rojas RL, St Sauver JL, et al
    Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
    PLoS One. 2020;15:e0233316.
    PubMed     Abstract available

  83. SHAWER H, Aiyelaagbe E, Clowes C, Lean SC, et al
    A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure.
    PLoS One. 2020;15:e0233007.
    PubMed     Abstract available

  84. ANWAR O, Gunawardene MA, Dickow J, Scherschel K, et al
    Contemporary analysis of phrenic nerve injuries following cryoballoon-based pulmonary vein isolation: A single-centre experience with the systematic use of compound motor action potential monitoring.
    PLoS One. 2020;15:e0235132.
    PubMed     Abstract available

  85. DE ROSA S, Sabatino J, Polimeni A, Sorrentino S, et al
    Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235511.
    PubMed     Abstract available

  86. TSAI BM, Sun JT, Hsieh MJ, Lin YY, et al
    Optimal paramedic numbers in resuscitation of patients with out-of-hospital cardiac arrest: A randomized controlled study in a simulation setting.
    PLoS One. 2020;15:e0235315.
    PubMed     Abstract available

  87. ZAPOLSKI T, Kaminska A, Kocki T, Wysokinski A, et al
    Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0236413.
    PubMed     Abstract available

  88. JILLELLA DV, Janocko NJ, Nahab F, Benameur K, et al
    Ischemic stroke in COVID-19: An urgent need for early identification and management.
    PLoS One. 2020;15:e0239443.
    PubMed     Abstract available

  89. ALAHMADI A, Davies A, Vigo M, Jay C, et al
    Pseudo-colouring an ECG enables lay people to detect QT-interval prolongation regardless of heart rate.
    PLoS One. 2020;15:e0237854.
    PubMed     Abstract available

  90. VAZE A, Tran KV, Tanriverdi K, Sardana M, et al
    Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study.
    PLoS One. 2020;15:e0236960.
    PubMed     Abstract available

  91. MOMO K, Shu-Toh K, Kaneko M, Yamanaka N, et al
    Predictive factors associated with bleeding in atrial fibrillation patients treated with anti-coagulant drugs using a large claims database.
    PLoS One. 2020;15:e0238233.
    PubMed     Abstract available

  92. BUCHHORN R, Baumann C, Gundogdu S, Rakowski U, et al
    Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients.
    PLoS One. 2020;15:e0238139.
    PubMed     Abstract available

  93. WALEK P, Gorczyca I, Sielski J, Wozakowska-Kaplon B, et al
    Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0238002.
    PubMed     Abstract available

  94. ROSE P, Schleimer JH, Schreiber S
    Modifications of sodium channel voltage dependence induce arrhythmia-favouring dynamics of cardiac action potentials.
    PLoS One. 2020;15:e0236949.
    PubMed     Abstract available

  95. UMEMURA T, Mashita S, Kawamura T
    Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
    PLoS One. 2020;15:e0238456.
    PubMed     Abstract available

  96. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available

  97. ZAMUDIO GS, Marquez MF, Jose MV
    Anticipation of ventricular tachyarrhythmias by a novel mathematical method: Further insights towards an early warning system in implantable cardioverter defibrillators.
    PLoS One. 2020;15:e0235101.
    PubMed     Abstract available

  98. NAKATA T, Doi A, Uta D, Yoshimura M, et al
    Excessive exercise induces cardiac arrhythmia in a young fibromyalgia mouse model.
    PLoS One. 2020;15:e0239473.
    PubMed     Abstract available

  99. MOSAYEBI A, Mojaradi B, Bonyadi Naeini A, Khodadad Hosseini SH, et al
    Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer.
    PLoS One. 2020;15:e0237658.
    PubMed     Abstract available

  100. KIM YG, Shim J, Boo KY, Kim DY, et al
    Slit-based irrigation catheters can reduce procedure-related ischemic stroke in atrial fibrillation patients undergoing radiofrequency catheter ablation.
    PLoS One. 2020;15:e0239339.
    PubMed     Abstract available

  101. WAN H, Selvaggio G, Pearlstein RA
    Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia.
    PLoS One. 2020;15:e0234946.
    PubMed     Abstract available

  102. PARK J, Choi EK, Han KD, Kim B, et al
    Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.
    PLoS One. 2020;15:e0240161.
    PubMed     Abstract available

  103. PATEL H, DiDomenico RJ, Suda KJ, Schumock GT, et al
    Risk of cardiac events with azithromycin-A prediction model.
    PLoS One. 2020;15:e0240379.
    PubMed     Abstract available

  104. MIYOSAWA K, Iwata H, Minami-Takano A, Hayashi H, et al
    Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation.
    PLoS One. 2020;15:e0240540.
    PubMed     Abstract available

  105. CHO HJ, Kang YJ, Sung SM, Ahn SH, et al
    Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests.
    PLoS One. 2020;15:e0240483.
    PubMed     Abstract available

  106. EVANS A, Davies M, Osborne V, Roy D, et al
    Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study.
    PLoS One. 2020;15:e0240489.
    PubMed     Abstract available

  107. SPRINGER A, Monsch AU, Dutilh G, Coslovsky M, et al
    A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF).
    PLoS One. 2020;15:e0240167.
    PubMed     Abstract available

  108. GUNASEKARAN T, Olivier B, Griffith L, Sanders R, et al
    Comparison of heart rate obtained from shorter duration Holter recordings to 24-hour mean heart rate in dogs with atrial fibrillation.
    PLoS One. 2020;15:e0241620.
    PubMed     Abstract available

  109. KAWAJI T, Shizuta S, Aizawa T, Yamagami S, et al
    Renal function and outcomes in atrial fibrillation patients after catheter ablation.
    PLoS One. 2020;15:e0241449.
    PubMed     Abstract available

  110. MIZOKAMI Y, Yamamoto T, Atarashi H, Yamashita T, et al
    Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
    PLoS One. 2020;15:e0240859.
    PubMed     Abstract available

  111. MATANGILA JR, Nyembu RK, Telo GM, Ngoy CD, et al
    Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
    PLoS One. 2020;15:e0244272.
    PubMed     Abstract available

  112. BANG OY, On YK, Lee MY, Jang SW, et al
    The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis.
    PLoS One. 2020;15:e0242922.
    PubMed     Abstract available

  113. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available

  114. DI DIEGO JM, Patocskai B, Barajas-Martinez H, Borbath V, et al
    Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
    PLoS One. 2020;15:e0242747.
    PubMed     Abstract available

  115. CHO JH, Namazi A, Shelton R, Ramireddy A, et al
    Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States.
    PLoS One. 2020;15:e0244533.
    PubMed     Abstract available

  116. SEO C, Michie C, Hibbert B, Davis DR, et al
    Systematic review of pre-clinical therapies for post-operative atrial fibrillation.
    PLoS One. 2020;15:e0241643.
    PubMed     Abstract available

  117. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    PubMed     Abstract available

  118. KOPONEN M, Marjamaa A, Tuiskula AM, Viitasalo M, et al
    Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation.
    PLoS One. 2020;15:e0243649.
    PubMed     Abstract available

  119. RIEG T, Frick J, Baumgartl H, Buettner R, et al
    Demonstration of the potential of white-box machine learning approaches to gain insights from cardiovascular disease electrocardiograms.
    PLoS One. 2020;15:e0243615.
    PubMed     Abstract available

  120. WU VC, Wang CL, Gan ST, Wu M, et al
    Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
    PLoS One. 2020;15:e0243866.
    PubMed     Abstract available

  121. SUZUKI A, Okamura T, Sasaki M, Matsuoka H, et al
    Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care.
    PLoS One. 2020;15:e0244240.
    PubMed     Abstract available

    January 2019
  122. YOU CH, Lin CK, Chen PH, Park S, et al
    Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226637.
    PubMed     Abstract available

  123. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    PubMed     Abstract available

  124. SHAKIBFAR S, Krause O, Lund-Andersen C, Strycko F, et al
    Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study.
    PLoS One. 2019;14:e0219533.
    PubMed     Abstract available

  125. WITASSEK F, Springer A, Adam L, Aeschbacher S, et al
    Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.
    PLoS One. 2019;14:e0226730.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.